Eucalyptus is a global telehealth provider building a safe, effective and accessible future for medicine. We evolve outdated systems to treat complex and chronic conditions, provide preventative healthcare, and advocate for better patient outcomes and safety.

We operate a trusted portfolio of digital clinics that deliver consults with certified practitioners, treatments, and ongoing care. Key brands include Kin (reproductive healthcare; founded 2020; over 50,000 contraceptive subscribers), Pilot (men’s health; serving 100,000+ men), Juniper (medical weight management for women; supporting ~200,000 patients across Australia, the UK, Germany and Japan), Compound (preventative health and performance for men), and Software (clinical-grade telehealth skincare; ~70,000 custom formulations and retail partnerships).

Eucalyptus advocates for patient safety, conducts research, and supports a global team of over 400 people. The organisation focuses on measurable patient results, clinical best practice, and scalable digital care models.